Der Abschied von den somatoformen Störungen: Neuerungen durch die Einführung der somatischen Belastungsstörung in ICD-11

2.

American Psychiatric Association

.

DSM III: Diagnostic and Statistical Manual of Mental Disorders

.

American Psychiatric Association

;

1980

.

3.

Asselmann

E

,

Wittchen

HU

,

Lieb

R

,

Beesdo-Baum

K

.

Sociodemographic, clinical, and functional long-term outcomes in adolescents and young adults with mental disorders

.

Acta Psychiatr Scand

.

2018

;

137

(

1

):

6

–

17

.

4.

Axelsson

E

,

Hedman-Lagerlöf

E

.

Validity and clinical utility of distinguishing between DSM-5 somatic symptom disorder and illness anxiety disorder in pathological health anxiety: Should we close the chapter

.

J Psychosom Res

.

2023

;

165

:

111133

.

5.

Bailer

J

,

Kerstner

T

,

Witthoft

M

,

Diener

C

,

Mier

D

,

Rist

F

.

Health anxiety and hypochondriasis in the light of DSM-5

.

Anxiety Stress Coping

.

2016

;

29

(

2

):

219

–

39

.

6.

Barrow

E

,

Oyebode

F

.

Body integrity identity disorder: clinical features and ethical dimensions

.

BJPsych Advances

.

2019

;

25

(

3

):

187

–

95

.

7.

Behm

AC

,

Hüsing

P

,

Löwe

B

,

Toussaint

A

.

Persistence rate of DSM-5 somatic symptom disorder: 4-year follow-up in patients from a psychosomatic outpatient clinic

.

Compr Psychiatry

.

2021

;

110

:

152265

.

8.

Behr

S

,

Fenski

F

,

Boettcher

J

,

Knaevelsrud

C

,

Hammelrath

L

,

Kovacs

G

, et al.

TONI-One for all? Participatory development of a transtheoretic and transdiagnostic online intervention for blended care

.

Internet Interv

.

2024

;

35

:

100723

.

9.

Briquet

P

.

Traité Clinique et Thérapeutique de l’Hystérie. J.-B. Baillière et fils

;

1859

.

10.

Bundesinstitut für Arzneimittel und Medizinprodukte

.

ICD-11 in Deutsch – Entwurfsfassung

.

2024

. Retrieved 26.09.2024 from: https://www.bfarm.de/DE/Kodiersysteme/Klassifikationen/ICD/ICD-11/uebersetzung/_node.html

11.

Bundesinstitut für Arzneimittel und Medizinprodukte

.

Verzeichnis digitale Gesundheitsanwendungen (DiGAs)

. Retrieved 29.09.2024 from https://diga.bfarm.de/de

12.

Chew-Graham

CA

,

Heyland

S

,

Kingstone

T

,

Shepherd

T

,

Buszewicz

M

,

Burroughs

H

, et al.

Medically unexplained symptoms: continuing challenges for primary care

.

Br J Gen Pract

.

2017

;

67

(

656

):

106

–

107

.

13.

Creed

F

.

The relationship between somatic symptoms, health anxiety, and outcome in medical out-patients

.

Psychiatr Clin North Am

.

2011

;

34

(

3

):

545

–

64

.

14.

Deary

V

,

Chalder

T

,

Sharpe

M

.

The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review

.

Clin Psychol Rev

.

2007

;

27

(

7

):

781

–

797

.

15.

Deutsche Schmerzgesellschaft

.

S3-Leitlinie: Definition, Ursachen, Diagnostik und Therapie des Fibromyalgiesyndroms

.

2017

. Retrieved 12.11.2024 from: https://register.awmf.org/de/leitlinien/detail/145-004

16.

Dimsdale

J

,

Levenson

J

.

What’s next for somatic symptom disorder

.

Am J Psychiatry

.

2013

;

170

(

12

):

1393

–

5

.

17.

Dimsdale

J

,

Sharma

N

,

Sharpe

M

.

What do physicians think of somatoform disorders

.

Psychosomatics

.

2011

;

52

(

2

):

154

–

9

.

18.

Dimsdale

JE

,

Creed

F

,

Escobar

J

,

Sharpe

M

,

Wulsin

L

,

Barsky

A

, et al.

Somatic symptom disorder: an important change in DSM

.

J Psychosom Res

.

2013

;

75

(

3

):

223

–

8

.

19.

Dumitrascu

DL

,

David

L

,

Baban

A

.

Is psychosomatic really a bicentennial word? The proof of an older use

.

Med Pharm Rep

.

2019

;

92

(

2

):

205

–

7

.

20.

Edgcomb

JB

,

Tseng

CH

,

Kerner

B

.

Medically unexplained somatic symptoms and bipolar spectrum disorders: a systematic review and meta-analysis

.

J Affect Disord

.

2016

;

204

:

205

–

13

.

21.

Engel

GL

.

The need for a new medical model: a challenge for biomedicine

.

Science

.

1977

;

196

(

4286

):

129

–

36

.

22.

Engelmann

P

,

Löwe

B

,

Hüsing

P

.

From the identification of biopsychosocial risk factors to an increase in pain-related self-efficacy (IDRIS) – The online-based conveyance of an explanatory model for chronic back pain: Study protocol of a cohort multiple randomized controlled trial

.

Internet Interv

.

2022

;

30

:

100582

.

. https://www.euronet-soma.eu/

23.

Euronet-Soma Group

.

EURONET-SOMA – European initiative to improve research, treatment, communication and collaboration on persistent somatic symptoms across the age span

.

2018

24.

Fanni

E

,

Castellini

G

,

Corona

G

,

Boddi

V

,

Ricca

V

,

Rastrelli

G

, et al.

The role of somatic symptoms in sexual medicine: somatization as important contextual factor in male sexual dysfunction

.

J Sex Med

.

2016

;

13

(

9

):

1395

–

407

.

25.

Fiertag

O

,

Taylor

S

,

Tareen

A

,

Garralda

E

.

Somatic symptom, bodily distress and related disorders in children and adolescents

.

IACAPAP e-textbook of child and adolescent mental health

.

2019

. p.

9

–

10

.

26.

First

M

,

Williams

J

,

Karg

R

,

Spitzer

R

.

Structured clinical interview for DSM-5 – Research version (SCID-5 for DSM-5, research version; SCID-5-RV)

.

Arlington, VA

:

American Psychiatric Association

;

2015

. p.

1

–

94

.

27.

First

MB

,

Clarke

DE

,

Yousif

L

,

Eng

AM

,

Gogtay

N

,

Appelbaum

PS

.

DSM-5-TR: rationale, process, and overview of changes

.

Psychiatr Serv

.

2023

;

74

(

8

):

869

–

75

.

28.

Fouradoulas

M

,

von Känel

R

,

Schmid

JP

.

Heart rate variability-state of research and clinical applicability

.

Praxis

.

2019

;

108

(

7

):

461

–

8

.

29.

Frances

A

.

The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill

.

BMJ

.

2013

;

346

:

f1580

.

30.

Fränkl

E

,

Hasenbank

N

,

Dumröse

K

,

Löwe

B

,

Kohlmann

S

.

Public and patient involvement in the development of an internet‐based guide for persistent somatic symptoms (GUIDE. PSS): a qualitative study on the needs of those affected

.

Health Expect

.

2024

;

27

(

1

):

e13931

.

31.

Gao

X

,

McSwiney

P

,

Court

A

,

Wiggins

A

,

Sawyer

S

.

Somatic symptom disorders in adolescent inpatients

.

J Adolesc Health

.

2018

;

63

(

6

):

779

–

84

.

32.

Gierk

B

,

Kohlmann

S

,

Kroenke

K

,

Spangenberg

L

,

Zenger

M

,

Brahler

E

, et al.

The somatic symptom scale-8 (SSS-8): a brief measure of somatic symptom burden

.

JAMA Intern Med

.

2014

;

174

(

3

):

399

–

407

.

33.

Gierk

B

,

Kohlmann

S

,

Toussaint

A

,

Wahl

I

,

Brünahl

CA

,

Murray

AM

, et al.

Assessing somatic symptom burden: a psychometric comparison of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8)

.

J Psychosom Res

.

2015

;

78

(

4

):

352

–

355

.

34.

Gupta

MA

.

Review of somatic symptoms in post-traumatic stress disorder

.

Int Rev Psychiatry

.

2013

;

25

(

1

):

86

–

99

.

35.

Gureje

O

,

Reed

GM

.

Bodily distress disorder in ICD‐11: problems and prospects

.

World Psychiatry

.

2016

;

15

(

3

):

291

–

292

.

36.

Guze

SB

.

The validity and significance of the clinical diagnosis of hysteria (Briquet’s syndrome)

.

Am J Psychiatry

.

1975

;

132

(

2

):

138

–

41

.

37.

Häuser

W

,

Hausteiner-Wiehle

C

,

Henningsen

P

,

Brähler

E

,

Schmalbach

B

,

Wolfe

F

.

Prevalence and overlap of somatic symptom disorder, bodily distress syndrome and fibromyalgia syndrome in the German general population: a cross sectional study

.

J Psychosom Res

.

2020

;

133

:

110111

.

38.

Heissel

A

,

Pietrek

A

,

Schwefel

M

,

Abula

K

,

Wilbertz

G

,

Heinzel

S

, et al.

STEP. De study – a multicentre cluster-randomised effectiveness trial of exercise therapy for patients with depressive symptoms in healthcare services: study protocol

.

BMJ Open

.

2020

;

10

(

4

):

e036287

.

39.

Hennemann

S

,

Böhme

K

,

Kleinstäuber

M

,

Baumeister

H

,

Küchler

AM

,

Ebert

DD

, et al.

Internet-based CBT for somatic symptom distress (iSOMA) in emerging adults: a randomized controlled trial

.

J Consult Clin Psychol

.

2022

;

90

(

4

):

353

–

65

.

40.

Hennemann

S

,

Böhme

K

,

Witthöft

M

.

Somatische Belastungsstörung und verwandte Störungen

.

Digitale Gesundheitsinterventionen: Anwendungen in Therapie und Prävention

.

Springer

;

2023

. p.

131

–

48

.

41.

Henningsen

P

.

Management of somatic symptom disorder

.

Dialogues Clin Neurosci

.

2018

;

20

(

1

):

23

–

31

.

42.

Henningsen

P

,

Gundel

H

,

Kop

WJ

,

Löwe

B

,

Martin

A

,

Rief

W

, et al.

Persistent physical symptoms as perceptual dysregulation: a neuropsychobehavioral model and its clinical implications

.

Psychosom Med

.

2018

a;

80

(

5

):

422

–

431

.

43.

Henningsen

P

,

Zipfel

S

,

Herzog

W

.

Management of functional somatic syndromes

.

Lancet

.

2007

;

369

(

9565

):

946

–

955

.

44.

Henningsen

P

,

Zipfel

S

,

Sattel

H

,

Creed

F

.

Management of functional somatic syndromes and bodily distress

.

Psychother Psychosom

.

2018

b;

87

(

1

):

12

–

31

.

45.

Herzog

A

,

Shedden-Mora

MC

,

Jordan

P

,

Löwe

B

.

Duration of untreated illness in patients with somatoform disorders

.

J Psychosom Res

.

2018

;

107

:

1

–

6

.

46.

Hiller

W

,

Rief

W

,

Brähler

E

.

Somatization in the population: from mild bodily misperceptions to disabling symptoms

.

Soc Psychiatry Psychiatr Epidemiol

.

2006

;

41

(

9

):

704

–

712

.

47.

Hinz

A

,

Ernst

J

,

Glaesmer

H

,

Brahler

E

,

Rauscher

FG

,

Petrowski

K

, et al.

Frequency of somatic symptoms in the general population: normative values for the Patient Health Questionnaire-15 (PHQ-15)

.

J Psychosom Res

.

2017

;

96

:

27

–

31

.

48.

Hinz

A

,

Rief

W

,

Brähler

E

.

Hypochondrie in der Allgemeinbevölkerung: Teststatistische Prüfung und Normierung des Whiteley-Index

.

Diagnostica

.

2003

;

49

(

1

):

34

–

42

.

49.

Hüsing

P

,

Löwe

B

,

Olde Hartman

TC

,

Frostholm

L

,

Weigel

A

.

Helpful explanatory models for somatoform symptoms (HERMES): study protocol of a randomised mixed-methods pilot trial

.

BMJ open

.

2021

;

11

(

3

):

e044244

.

50.

Hüsing

P

,

Löwe

B

,

Toussaint

A

.

Comparing the diagnostic concepts of ICD-10 somatoform disorders and DSM-5 somatic symptom disorders in patients from a psychosomatic outpatient clinic

.

J Psychosom Res

.

2018

;

113

:

74

–

80

.

51.

Hüsing

P

,

Smakowski

A

,

Löwe

B

,

Kleinstäuber

M

,

Toussaint

A

,

Shedden-Mora

MC

.

The framework for systematic reviews on psychological risk factors for persistent somatic symptoms and related syndromes and disorders (PSY-PSS)

.

Front Psychiatry

.

2023

;

14

:

1142484

.

52.

Junge

M

,

Hüsing

P

,

Löwe

B

,

Weigel

A

.

Patients’ acceptance of explanatory models for persistent somatic symptoms: a qualitative analysis within the HERMES study

.

J Psychosom Res

.

2023

;

170

:

111347

.

53.

Kapfhammer

H

.

Somatoforme Störungen: Historische Entwicklung und moderne diagnostische Konzeptualisierung

.

Nervenarzt

.

2001

;

72

(

7

):

487

–

500

.

54.

Katsamanis

M

,

Lehrer

PM

,

Escobar

JI

,

Gara

MA

,

Kotay

A

,

Liu

R

.

Psychophysiologic treatment for patients with medically unexplained symptoms: a randomized controlled trial

.

Psychosomatics

.

2011

;

52

(

3

):

218

–

29

.

55.

Keeley

J

,

Reed

GM

,

Rebello

T

,

Brechbiel

J

,

Garcia-Pacheco

JA

,

Adebayo

K

, et al.

Case-controlled field study of the ICD-11 clinical descriptions and diagnostic requirements for bodily distress disorders

.

J Affect Disord

.

2023

;

333

:

271

–

7

.

56.

Kleinschmidt

J

,

Köllner

V

.

Herz und Psyche in Bewegung bringen

.

PiD-Psychotherapie im Dialog

.

2021

;

22

(

02

):

82

–

6

.

57.

Kleinstäuber

M

,

Lambert

MJ

,

Hiller

W

.

Early response in cognitive-behavior therapy for syndromes of medically unexplained symptoms

.

BMC Psychiatry

.

2017

;

17

(

1

):

195

.

58.

Kleinstäuber

M

,

Thomas

P

,

Witthöft

M

,

Hiller

W

.

Kognitive Verhaltenstherapie bei medizinisch unerklärten Körperbeschwerden und somatoformen Störungen

.

Springer

;

2017

.

59.

Kleinstäuber

M

,

Witthoft

M

,

Hiller

W

.

Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis

.

Clin Psychol Rev

.

2011

;

31

(

1

):

146

–

60

.

60.

Kleinstäuber

M

,

Witthoft

M

,

Steffanowski

A

,

van Marwijk

H

,

Hiller

W

,

Lambert

MJ

.

Pharmacological interventions for somatoform disorders in adults

.

Cochrane Database Syst Rev

.

2014

;

2014

:

CD010628

.

61.

Konnopka

A

,

Schaefert

R

,

Heinrich

S

,

Kaufmann

C

,

Luppa

M

,

Herzog

W

, et al.

Economics of medically unexplained symptoms: a systematic review of the literature

.

Psychother Psychosom

.

2012

;

81

(

5

):

265

–

75

.

62.

Korwisi

B

,

Barke

A

.

Chronische Schmerzen in der 11. Auflage der Internationalen Statistischen Klassifikation der Krankheiten und verwandter Gesundheitsprobleme

.

Psychotherapie

.

2024

;

69

:

231

–

6

.

63.

Krempel

L

,

Martin

A

.

Efficacy of heart rate variability biofeedback for somatic symptom disorder: a pilot randomized controlled trial

.

Psychosom Med

.

2023

;

85

(

1

):

61

–

70

.

64.

Kroenke

K

.

Patients presenting with somatic complaints: epidemiology, psychiatric co-morbidity and management

.

Int J Methods Psychiatr Res

.

2003

;

12

(

1

):

34

–

43

.

65.

Kroenke

K

,

Spitzer

RL

,

Williams

JB

,

Löwe

B

.

The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review

.

Gen Hosp Psychiatry

.

2010

;

32

(

4

):

345

–

59

.

66.

Lee

S

,

Creed

FH

,

Ma

YL

,

Leung

CM

.

Somatic symptom burden and health anxiety in the population and their correlates

.

J Psychosom Res

.

2015

;

78

(

1

):

71

–

6

.

67.

Lehmann

M

,

Jonas

C

,

Pohontsch

NJ

,

Zimmermann

T

,

Scherer

M

,

Löwe

B

.

General practitioners’ views on the diagnostic innovations in DSM-5 somatic symptom disorder – a focus group study

.

J Psychosom Res

.

2019

;

123

:

109734

.

68.

Leiknes

KA

,

Finset

A

,

Moum

T

,

Sandanger

I

.

Methodological issues concerning lifetime medically unexplained and medically explained symptoms of the Composite International Diagnostic Interview: a prospective 11-year follow-up study

.

J Psychosom Res

.

2006

;

61

(

2

):

169

–

79

.

69.

Limburg

K

,

Sattel

H

,

Dinkel

A

,

Radziej

K

,

Becker-Bense

S

,

Lahmann

C

.

Course and predictors of DSM-5 somatic symptom disorder in patients with vertigo and dizziness symptoms – a longitudinal study

.

Compr Psychiatry

.

2017

;

77

:

1

–

11

.

70.

Löwe

B

,

Andresen

V

,

Van den Bergh

O

,

Huber

TB

,

von dem Knesebeck

O

,

Lohse

AW

, et al.

Persistent SOMAtic symptoms ACROSS diseases – from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211)

.

BMJ Open

.

2022

;

12

(

1

):

e057596

.

71.

Löwe

B

,

Gerloff

C

.

Functional somatic symptoms across cultures: perceptual and health care issues

.

Psychosom Med

.

2018

;

80

(

5

):

412

–

5

.

72.

Löwe

B

,

Levenson

J

,

Depping

M

,

Hüsing

P

,

Kohlmann

S

,

Lehmann

M

, et al.

Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis

.

Psychol Med

.

2021

;

52

(

4

):

632

–

48

.

73.

Löwe

B

,

Lohse

A

,

Andresen

V

,

Vettorazzi

E

,

Rose

M

,

Broicher

W

.

The development of irritable bowel syndrome: a prospective community-based cohort study

.

Am J Gastroenterol

.

2016

;

111

(

9

):

1320

–

29

.

74.

Löwe

BT

,

Toussaint

A

,

Rosmalen

JGM

,

Huang

WL

,

Burton

C

,

Weigel

A

, et al.

Persistent physical symptoms: definition, genesis, and management

.

Lancet

.

2024

;

403

(

10444

):

2649

–

62

.

75.

Mai

F

.

Briquet’s syndrome (hysteria) and the physician

.

Can Med Assoc J

.

1982

;

127

(

2

):

99

–

100

.

76.

Martin

A

,

Rief

W

.

Wie wirksam ist Biofeedback? Eine therapeutische Methode. Hogrefe AG

;

2008

.

77.

McFarlane

AC

,

Ellis

N

,

Barton

C

,

Browne

D

,

Van Hooff

M

.

The conundrum of medically unexplained symptoms: questions to consider

.

Psychosomatics

.

2008

;

49

(

5

):

369

–

77

.

78.

Minen

MT

,

Stieglitz

EJ

,

Sciortino

R

,

Torous

J

.

Privacy issues in smartphone applications: an analysis of headache/migraine applications

.

Headache: The Journal of Head and Face Pain

.

2018

;

58

(

7

):

1014

–

27

.

79.

Morschitzky

H

.

Somatoforme Störungen. Diagnostik, Konzepte und Therapie bei Körpersymptomen ohne Organbefund

.

Springer

;

2007

.

80.

Nanke

A

,

Rief

W

.

Biofeedback-based interventions in somatoform disorders: a randomized controlled trial

.

Acta Neuropsychiatr

.

2003

;

15

(

4

):

249

–

56

.

81.

Nationale Versorgungsleitlinie

.

Nicht-spezifischer Kreuzschmerz. AWMF-Registernr: nvl-007

.

2017

.

82.

Newby

JM

,

Hobbs

MJ

,

Mahoney

AEJ

,

Wong

SK

,

Andrews

G

.

DSM-5 illness anxiety disorder and somatic symptom disorder: comorbidity, correlates, and overlap with DSM-IV hypochondriasis

.

J Psychosom Res

.

2017

;

101

:

31

–

7

.

83.

Noetel

M

,

Sanders

T

,

Gallardo-Gómez

D

,

Taylor

P

,

del Pozo Cruz

B

,

Van Den Hoek

D

, et al.

Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials

.

BMJ

.

2024

;

384

:

e075847

.

84.

North

CS

.

The classification of hysteria and related disorders: historical and phenomenological considerations

.

Behav Sci

.

2015

;

5

(

4

):

496

–

517

.

85.

O’Neill

S

,

Brady

R

.

Colorectal smartphone apps: opportunities and risks

.

Colorectal Dis

.

2012

;

14

(

9

):

e530

–

e534

.

86.

Park

J

,

Gilmour

H

.

Medically unexplained physical symptoms (MUPS) among adults in Canada: comorbidity, health care use and employment

.

Health Rep

.

2017

;

28

(

3

):

3

–

8

.

87.

Rask

CU

,

Bonvanie

IJ

,

Garralda

EM

.

Risk and protective factors and course of functional somatic symptoms in young people

.

Understanding uniqueness and diversity in child and adolescent mental health

.

Elsevier

;

2018

. p.

77

–

113

.

88.

Rask

MT

,

Rosendal

M

,

Fenger-Gron

M

,

Bro

F

,

Ørnbøl

E

,

Fink

P

.

Sick leave and work disability in primary care patients with recent-onset multiple medically unexplained symptoms and persistent somatoform disorders: a 10-year follow-up of the FIP study

.

Gen Hosp Psychiatry

.

2015

;

37

(

1

):

53

–

9

.

89.

Reid

S

,

Wessely

S

,

Crayford

T

,

Hotopf

M

.

Medically unexplained symptoms in frequent attenders of secondary health care: retrospective cohort study

.

BMJ

.

2001

;

322

(

7289

):

767

.

90.

Rief

W.

.

Somatisierungsstörung

.

Verhaltenstherapiemanual

.

Springer

;

2011

. p.

655

–

59

.

91.

Rief

W

,

Broadbent

E

.

Explaining medically unexplained symptoms-models and mechanisms

.

Clin Psychol Rev

.

2007

;

27

(

7

):

821

–

41

.

92.

Rief

W

,

Martin

A

.

How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications

.

Annu Rev Clin Psychol

.

2014

;

10

:

339

–

67

.

93.

Rief

W

,

Schaefer

S

,

Hiller

W

,

Fichter

MM

.

Lifetime diagnoses in patients with somatoform disorders: which came first

.

Eur Arch Psychiatry Clin Neurosci

.

1992

;

241

(

4

):

236

–

40

.

94.

Roenneberg

C

,

Hausteiner-Wiehle

C

,

Henningsen

P

.

„Funktionelle Körperbeschwerden“: Klinisch relevante Leitlinien-Empfehlungen

.

PSYCH up2date

.

2020

;

14

(

01

):

35

–

53

.

95.

Roenneberg

C

,

Sattel

H

,

Schaefert

R

,

Henningsen

P

,

Hausteiner-Wiehle

C

.

Clinical practice guideline: functional somatic symptoms

.

Dtsch Ärztebl Int

.

2019

;

116

(

33-34

):

553

–

60

.

96.

Rosmalen

J

,

Burton

C

,

Carson

A

,

Cosci

F

,

Frostholm

L

,

Lehnen

N

, et al.

The European training network ETUDE (encompassing training in functional disorders across Europe) is recruiting 15 early-stage researchers

.

Psychother Psychosom

.

2021

;

90

(

2

):

142

–

3

.

97.

Schur

M

.

Comments on the metapsychology of somatization

.

The psychoanalytic study of the child

.

1955

;

10

(

1

):

119

–

64

.

98.

Sharpe

M

,

Mayou

R

,

Walker

J

.

Bodily symptoms: new approaches to classification

.

J Psychosom Res

.

2006

;

60

(

4

):

353

–

6

.

99.

Smakowski

AL

,

Hüsing

P

,

Völcker

S

,

Löwe

B

,

Rosmalen

JG

,

Shedden-Mora

M

, et al.

Psychological risk factors of somatic symptom disorder: a systematic review and meta-analysis of cross-sectional and longitudinal studies

.

J Psychosom Res

.

2024

;

181

:

111608

.

100.

Stein

D

,

Kogan

C

,

Atmaca

M

,

Fineberg

N

,

Fontenelle

L

,

Grant

J

, et al.

The classification of obsessive–compulsive and related disorders in the ICD-11

.

J Affect Disord

.

2016

;

190

:

663

–

74

.

101.

Ströhle

A

,

Höfler

M

,

Pfister

H

,

Müller

AG

,

Hoyer

J

,

Wittchen

HU

, et al.

Physical activity and prevalence and incidence of mental disorders in adolescents and young adults

.

Psychol Med

.

2007

;

37

(

11

):

1657

–

66

.

102.

Tack

M

.

Medically unexplained symptoms (MUS): faults and implications

.

Int J Environ Res Public Health

.

2019

;

16

(

7

):

1247

.

103.

Terhorst

Y

,

Messner

EM

,

Schultchen

D

,

Paganini

S

,

Portenhauser

A

,

Eder

AS

, et al.

Systematic evaluation of content and quality of English and German pain apps in European app stores

.

Internet Interv

.

2021

;

24

:

100376

.

104.

Torres

ME

,

Löwe

B

,

Schmitz

S

,

Pienta

JN

,

Van Der Feltz-Cornelis

C

,

Fiedorowicz

JG

.

Suicide and suicidality in somatic symptom and related disorders: a systematic review

.

J Psychosom Res

.

2021

;

140

:

110290

.

105.

Toussaint

A

,

Hüsing

P

,

Kohlmann

S

,

Brähler

E

,

Löwe

B

.

Excessiveness in symptom-related thoughts, feelings, and behaviors: an investigation of somatic symptom disorders in the general population

.

Psychosom Med

.

2021

;

83

(

2

):

164

–

70

.

106.

Toussaint

A

,

Hüsing

P

,

Kohlmann

S

,

Löwe

B

.

Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder – B Criteria Scale (SSD-12)

.

Psychol Med

.

2020

;

50

(

2

):

324

–

33

.

107.

Toussaint

A

,

Murray

AM

,

Voigt

K

,

Herzog

A

,

Gierk

B

,

Kroenke

K

, et al.

Development and validation of the Somatic Symptom Disorder-B Criteria Scale (SSD-12)

.

Psychosom Med

.

2016

;

78

(

1

):

5

–

12

.

108.

Treede

RD

,

Rief

W

,

Barke

A

,

Aziz

Q

,

Bennett

MI

,

Benoliel

R

, et al.

Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)

.

Pain

.

2019

;

160

(

1

):

19

–

27

.

109.

The Lancet

.

Taking persistent physical symptoms seriously

.

Lancet

.

2024

;

403

(

10444

):

2565

.

110.

Van Dessel

N

,

Den Boeft

M

,

van der Wouden

JC

,

Kleinstäuber

M

,

Leone

SS

,

Terluin

B

, et al.

Non-pharmacological interventions for somatoform disorders and medically-unexplained physical symptoms (MUPS) in adults

.

Cochrane Database Syst Rev

.

2014

;

2014

(

11

):

CD011142

–

17

.

111.

van Geelen

SM

,

Rydelius

PA

,

Hagquist

C

.

Somatic symptoms and psychological concerns in a general adolescent population: exploring the relevance of DSM-5 somatic symptom disorder

.

J Psychosom Res

.

2015

;

79

(

4

):

251

–

8

.

112.

Voigt

K

,

Nagel

A

,

Meyer

B

,

Langs

G

,

Braukhaus

C

,

Löwe

B

.

Towards positive diagnostic criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification

.

J Psychosom Res

.

2010

;

68

(

5

):

403

–

14

.

. , http://www.ncbi.nlm.nih.gov/pubmed/23062807

113.

Voigt

K

,

Wollburg

E

,

Weinmann

N

,

Herzog

A

,

Meyer

B

,

Langs

G

, et al.

Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder – comparison with DSM-IV somatoform disorders and additional criteria for consideration

.

J Psychosom Res

.

2012

;

73

(

5

):

345

–

350

114.

Voigt

K

,

Wollburg

E

,

Weinmann

N

,

Herzog

A

,

Meyer

B

,

Langs

G

, et al.

Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder: prospective 1-year follow-up study

.

J Psychosom Res

.

2013

;

75

(

4

):

358

–

61

.

115.

von dem Knesebeck

O

,

Lehmann

M

,

Löwe

B

,

Makowski

AC

.

Public stigma towards individuals with somatic symptom disorders – Survey results from Germany

.

J Psychosom Res

.

2018

;

115

:

71

–

75

.

116.

Vugts

MA

,

Joosen

MC

,

van der Geer

JE

,

Zedlitz

AM

,

Vrijhoef

HJ

.

The effectiveness of various computer-based interventions for patients with chronic pain or functional somatic syndromes: a systematic review and meta-analysis

.

PLoS One

.

2018

;

13

(

5

):

e0196467

.

117.

Weigel

A

,

Hüsing

P

,

Junge

M

,

Löwe

B

.

Helpful explanatory models for persistent somatic symptoms (HERMES): results of a three-arm randomized-controlled pilot trial

.

J Psychosom Res

.

2023

;

172

:

111419

.

118.

Weigel

A

,

Hüsing

P

,

Kohlmann

S

,

Lehmann

M

,

Shedden-Mora

M

,

Toussaint

A

, et al.

A European research network to improve diagnosis, treatment and care for patients with persistent somatic symptoms: work report of the EURONET-SOMA conference series

.

J Psychosom Res

.

2017

;

97

:

136

–

8

.

119.

Weigel

A

,

Maehder

K

,

Witt

M

,

Löwe

B

.

Psychotherapists’ perspective on the treatment of patients with somatic symptom disorders

.

J Psychosom Res

.

2020

;

138

:

110228

.

120.

Weise

C

,

Kaiser

G

,

Janda

C

,

Kues

JN

,

Andersson

G

,

Strahler

J

, et al.

Internet-based cognitive-behavioural intervention for women with premenstrual dysphoric disorder: a randomized controlled trial

.

Psychother Psychosom

.

2019

;

88

(

1

):

16

–

29

.

121.

Weise

C

,

Kleinstäuber

M

,

Andersson

G

.

Internet-delivered cognitive-behavior therapy for tinnitus: a randomized controlled trial

.

Psychosom Med

.

2016

;

78

(

4

):

501

–

10

.

122.

Wiborg

JF

,

Gieseler

D

,

Fabisch

AB

,

Voigt

K

,

Lautenbach

A

,

Löwe

B

.

Suicidality in primary care patients with somatoform disorders

.

Psychosom Med

.

2013

;

75

(

9

):

800

–

6

.

123.

Wolf

S

,

Seiffer

B

,

Zeibig

JM

,

Frei

AK

,

Studnitz

T

,

Welkerling

J

, et al.

A transdiagnostic group exercise intervention for mental health outpatients in Germany (ImPuls): results of a pragmatic, multisite, block-randomised, phase 3 controlled trial

.

Lancet Psychiatry

.

2024

;

11

(

6

):

417

–

30

.

124.

Wollburg

E

,

Voigt

K

,

Braukhaus

C

,

Herzog

A

,

Löwe

B

.

Construct validity and descriptive validity of somatoform disorders in light of proposed changes for the DSM-5

.

J Psychosom Res

.

2013

;

74

(

1

):

18

–

24

.